← back to search

Khaled Barakat

Technical University of Munich · EG
Area of research
Computational Theory and Mathematics · Molecular Biology
Research interest
Research interests include Computational Drug Discovery Methods, Cardiac electrophysiology and arrhythmias, Cancer Immunotherapy and Biomarkers, and Receptor Mechanisms and Signaling.
h-index
36
citations
3,958
works
176
NIH funding
primary concept
email

Recent publications

Therapeutic potential of TIM-3 inhibition in cancer, viral infections, and autoimmune disorders.
2025cited by 1position: contributordoi
Designing a multi-neoantigen vaccine for melanoma: Integrating immunoinformatics and biophysics methods.
2025cited by 1position: contributordoi
Indirect Modeling of Post-Prandial Intestinal Lymphatic Uptake of Halofantrine Using PBPK Approaches: Limitations and Implications.
2025cited by 0position: contributordoi
Benchmarking of Small Molecule Feature Representations for hERG, Nav1.5, and Cav1.2 Cardiotoxicity Prediction.
2024cited by 20position: contributordoi
Investigating the Aryl Hydrocarbon Receptor Agonist/Antagonist Conformational Switch Using Well-Tempered Metadynamics Simulations.
2024cited by 4position: contributordoi
The Sodium/Glucose Cotransporter 2 Inhibitor Empagliflozin Inhibits Long QT 3 Late Sodium Currents in a Mutation Specific Manner
2024cited by 0position: contributordoi
The Anticancer Potential of <i>Psidium guajava</i> (Guava) Extracts.
2023cited by 12position: contributordoi
Discovery of allosteric SHP2 inhibitors through ensemble-based consensus molecular docking, endpoint and absolute binding free energy calculations.
2023cited by 5position: contributordoi
Benchmarking of Small Molecule Feature Representations for hERG, Nav1.5, and Cav1.2 Cardiotoxicity Prediction
2023cited by 0position: contributordoi
Assessing Molecular Docking Tools to Guide the Design of Polymeric Materials Formulations: A Case Study of Canola and Soybean Protein.
2022cited by 10position: contributordoi
The Effect of Aflatoxin B1 on Tumor-Related Genes and Phenotypic Characters of MCF7 and MCF10A Cells.
2022cited by 4position: contributordoi
Leveraging structural and 2D-QSAR to investigate the role of functional group substitutions, conserved surface residues and desolvation in triggering the small molecule-induced dimerization of hPD-L1.
2022cited by 3position: contributordoi
β-Caryophyllene Induces Apoptosis and Inhibits Angiogenesis in Colorectal Cancer Models.
2021cited by 27position: contributordoi
GRP78: A possible relationship of COVID-19 and the mucormycosis; in silico perspective.
2021cited by 13position: contributordoi
Targeting B7-1 in immunotherapy.
2020cited by 50position: contributordoi
Design, synthesis, biological evaluation and dynamics simulation of indazole derivatives with antiangiogenic and antiproliferative anticancer activity.
2019cited by 24position: contributordoi
Atomistic modeling and molecular dynamics analysis of human Ca<sub>V</sub>1.2 channel using external electric field and ion pulling simulations.
2019cited by 14position: contributordoi
Structure-based screening and validation of potential dengue virus inhibitors through classical and QM/MM affinity estimation.
2019cited by 3position: contributordoi
Human PD-1 binds differently to its human ligands: A comprehensive modeling study
Journal of Molecular Graphics and Modelling 2015cited by 48position: lastdoi
Small Molecule Inhibitors of ERCC1-XPF Protein-Protein Interaction Synergize Alkylating Agents in Cancer Cells
Molecular Pharmacology 2013cited by 89position: middledoi
Computational Predictions of Volatile Anesthetic Interactions with the Microtubule Cytoskeleton: Implications for Side Effects of General Anesthesia
PLoS ONE 2012cited by 81position: middledoi
Virtual Screening and Biological Evaluation of Inhibitors Targeting the XPA-ERCC1 Interaction
PLoS ONE 2012cited by 71position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Jack A. Tuszyński · Tufts University3 papers (2012–2013) · 3 papers (2020–2024)Rolando Pérez · Université Claude Bernard Lyon 12 papers (2012–2013)Lars Petter Jordheim · Institut des Sciences Analytiques2 papers (2012–2013)Wout Bittremieux · Biomedical Informatics Research Center Antwerp2 papers (2023–2024)David S. Wishart · Pharmaceutical Biotechnology (Czechia)2 papers (2012–2013)Charles Dumontet · Clinica Universidad de Navarra2 papers (2012–2013) · 1 papers (2015–2015)Eva‐Laure Matera · Centre de Recherche en Cancérologie de Lyon1 papers (2013–2013)Clement Viricel · Université Claude Bernard Lyon 11 papers (2015–2015)Laurence Heinrich-Balard · Université Claude Bernard Lyon 11 papers (2013–2013)K. Bouledrak · Université Claude Bernard Lyon 11 papers (2013–2013)Stuart R. Hameroff · University of Arizona1 papers (2012–2012)Emeline Cros‐Perrial · Université Claude Bernard Lyon 11 papers (2013–2013) · 1 papers (2012–2012)Richard Cohen · Université Claude Bernard Lyon 11 papers (2013–2013) · 1 papers (2024–2024)Shokrollah Elahi · Alberta Biodiversity Monitoring Institute1 papers (2020–2020)Issar Arab · Elsevier, Inc.1 papers (2023–2023)Kris Laukens · University of Antwerp1 papers (2023–2023)